145 related articles for article (PubMed ID: 15474044)
21. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
22. The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2.
Tong Y; Wei J; Zhang S; Strong JA; Dlouhy SR; Hodes ME; Ghetti B; Yu L
FEBS Lett; 1996 Jul; 390(1):63-8. PubMed ID: 8706831
[TBL] [Abstract][Full Text] [Related]
23. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.
Browne DL; Gancher ST; Nutt JG; Brunt ER; Smith EA; Kramer P; Litt M
Nat Genet; 1994 Oct; 8(2):136-40. PubMed ID: 7842011
[TBL] [Abstract][Full Text] [Related]
24. Changes of activation and inactivation gating of the transient potassium current of rat pituitary melanotrophs caused by micromolar Cd2+ and Zn2+.
Davidson JL; Kehl SJ
Can J Physiol Pharmacol; 1995 Jan; 73(1):36-42. PubMed ID: 7600450
[TBL] [Abstract][Full Text] [Related]
25. The episodic ataxia type 1 mutation I262T alters voltage-dependent gating and disrupts protein biosynthesis of human Kv1.1 potassium channels.
Chen SH; Fu SJ; Huang JJ; Tang CY
Sci Rep; 2016 Jan; 6():19378. PubMed ID: 26778656
[TBL] [Abstract][Full Text] [Related]
26. Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency.
Zerr P; Adelman JP; Maylie J
J Neurosci; 1998 Apr; 18(8):2842-8. PubMed ID: 9526001
[TBL] [Abstract][Full Text] [Related]
27. Inactivation gating of Kv4 potassium channels: molecular interactions involving the inner vestibule of the pore.
Jerng HH; Shahidullah M; Covarrubias M
J Gen Physiol; 1999 May; 113(5):641-60. PubMed ID: 10228180
[TBL] [Abstract][Full Text] [Related]
28. An activator of voltage-gated K
Servettini I; Talani G; Megaro A; Setzu MD; Biggio F; Briffa M; Guglielmi L; Savalli N; Binda F; Delicata F; Bru-Mercier G; Vassallo N; Maglione V; Cauchi RJ; Di Pardo A; Collu M; Imbrici P; Catacuzzeno L; D'Adamo MC; Olcese R; Pessia M
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2207978120. PubMed ID: 37487086
[TBL] [Abstract][Full Text] [Related]
29. Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
Harrison NL; Radke HK; Tamkun MM; Lovinger DM
Mol Pharmacol; 1993 Mar; 43(3):482-6. PubMed ID: 8450837
[TBL] [Abstract][Full Text] [Related]
30. A Common Kinetic Property of Mutations Linked to Episodic Ataxia Type 1 Studied in the Shaker Kv Channel.
Zhao J; Petitjean D; Haddad GA; Batulan Z; Blunck R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066705
[TBL] [Abstract][Full Text] [Related]
31. Modulation of voltage sensitivity by N-terminal cytoplasmic residues in human Kv1.2 channels.
Varshney A; S K; Mathew MK
Eur Biophys J; 2002 Sep; 31(5):365-72. PubMed ID: 12202912
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in
Lauxmann S; Sonnenberg L; Koch NA; Bosselmann C; Winter N; Schwarz N; Wuttke TV; Hedrich UBS; Liu Y; Lerche H; Benda J; Kegele J
Front Neurol; 2021; 12():703970. PubMed ID: 34566847
[No Abstract] [Full Text] [Related]
33. Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
Manville RW; Abbott GW
J Pharmacol Exp Ther; 2020 Jun; 373(3):391-401. PubMed ID: 32217768
[TBL] [Abstract][Full Text] [Related]
34. Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.
Yuan H; Yuan H; Wang Q; Ye W; Yao R; Xu W; Liu Y
Mol Genet Genomic Med; 2020 Oct; 8(10):e1434. PubMed ID: 32705822
[TBL] [Abstract][Full Text] [Related]
35. Role of the S2 and S3 segment in determining the activation kinetics in Kv2.1 channels.
Koopmann R; Scholle A; Ludwig J; Leicher T; Zimmer T; Pongs O; Benndorf K
J Membr Biol; 2001 Jul; 182(1):49-59. PubMed ID: 11426299
[TBL] [Abstract][Full Text] [Related]
36. Episodic ataxia and myokymia syndrome: a new mutation of potassium channel gene Kv1.1.
Comu S; Giuliani M; Narayanan V
Ann Neurol; 1996 Oct; 40(4):684-7. PubMed ID: 8871592
[TBL] [Abstract][Full Text] [Related]
37. Gating and flickery block differentially affected by rubidium in homomeric KCNQ1 and heteromeric KCNQ1/KCNE1 potassium channels.
Pusch M; Bertorello L; Conti F
Biophys J; 2000 Jan; 78(1):211-26. PubMed ID: 10620287
[TBL] [Abstract][Full Text] [Related]
38. The inherited episodic ataxias: how well do we understand the disease mechanisms?
Kullmann DM; Rea R; Spauschus A; Jouvenceau A
Neuroscientist; 2001 Feb; 7(1):80-8. PubMed ID: 11486347
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of functional interaction between K(+) channel alpha- and beta-subunits and putative inactivation gating by Co-expression in Xenopus laevis oocytes.
Zhang X; Ma J; Berkowitz GA
Plant Physiol; 1999 Nov; 121(3):995-1002. PubMed ID: 10557249
[TBL] [Abstract][Full Text] [Related]
40. The effects of ginsenoside Rg(3) on human Kv1.4 channel currents without the N-terminal rapid inactivation domain.
Lee JH; Choi SH; Lee BH; Shin TJ; Pyo MK; Hwang SH; Kim BR; Lee SM; Bae DH; Rhim H; Nah SY
Biol Pharm Bull; 2009 Apr; 32(4):614-8. PubMed ID: 19336893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
